| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 11 929-937, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
C Aperlo, L Sevilla, S Guerin, P Pognonec and KE Boulukos
Centre de Biochimie, Faculte des Sciences, Nice, France.
Cells of the M1D+ murine myeloid leukemic cell line differentiate into macrophages in response to either leukemia inhibitory factor (LIF) or interleukin 6. Previously, it was shown that LIF treatment of M1D+ cells leads to an increased expression of colony-stimulating factor (CSF) receptor mRNA encoded by c-fms. CSF-1, a macrophage growth factor, induces the survival, growth, and differentiation of mononuclear phagocytes but has not been implicated in the regulation of early myeloid cell differentiation. Here we show that low-dose LIF treatment of M1D+ cells results in CSF-1 secretion and CSF-1 receptor up-regulation. CSF-1, when applied alone, induces some M1D+ adherence and the up-regulation of lysozyme M, a macrophage-specific marker. Finally, we show that when applied together, LIF and CSF-1 act synergistically to induce macrophage morphology, phagocytosis, and the expression of the macrophage-specific markers CD11b/Mac-1 alpha chain, lysozyme M, FcgammaRII, and JE/MCP.1. These results indicate that instead of being part of exclusive pathways, as thought until this work, LIF and CSF-1 can function synergistically to further stimulate the early stages of myeloid differentiation.
This article has been cited by other articles:
![]() |
J. A. Hamilton, G. Whitty, P. Masendycz, N. J. Wilson, J. Jackson, D. De Nardo, and G. M. Scholz The Critical Role of the Colony-Stimulating Factor-1 Receptor in the Differentiation of Myeloblastic Leukemia Cells Mol. Cancer Res., March 1, 2008; 6(3): 458 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rosenberger, M. G. Scott, M. R. Gold, R. E. W. Hancock, and B. B. Finlay Salmonella typhimurium Infection and Lipopolysaccharide Stimulation Induce Similar Changes in Macrophage Gene Expression J. Immunol., June 1, 2000; 164(11): 5894 - 5904. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sevilla, A. Zaldumbide, F. Carlotti, M. A. Dayem, P. Pognonec, and K. E. Boulukos Bcl-xL Expression Correlates with Primary Macrophage Differentiation, Activation of Functional Competence, and Survival and Results from Synergistic Transcriptional Activation by Ets2 and PU.1 J. Biol. Chem., May 18, 2001; 276(21): 17800 - 17807. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Bourette, P. De Sepulveda, S. Arnaud, P. Dubreuil, R. Rottapel, and G. Mouchiroud Suppressor of Cytokine Signaling 1 Interacts with the Macrophage Colony-stimulating Factor Receptor and Negatively Regulates Its Proliferation Signal J. Biol. Chem., June 15, 2001; 276(25): 22133 - 22139. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |